文献速递产科母胎医学

COVID-19孕妇疾病严重程度与围产结局

Disease Severity and Perinatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 (COVID-19).
PubMed 文献 · Obstet Gynecol · 2021-01-01

这项观察性队列研究纳入2020年3月至7月美国33家医院分娩的1219例SARS-CoV-2阳性单胎孕妇,按NIH标准分级。重度-危重型COVID-19与剖宫产、妊娠期高血压疾病和早产风险增加相关,而轻-中型与无症状者围产结局无差异。

要点

  • 重度-危重型COVID-19孕妇剖宫产、妊娠期高血压疾病和早产风险显著增加。
  • 轻-中型COVID-19孕妇围产结局与无症状者无显著差异。
  • 围产儿死亡或新生儿SARS-CoV-2阳性率不随疾病严重程度变化。

核心结论

  • 与无症状SARS-CoV-2感染孕妇相比,重度-危重型COVID-19孕妇围产并发症风险增加,而轻-中型感染者未见风险增加。

研究设计与样本

  • 观察性队列研究,纳入2020年3月1日至7月31日美国14州33家医院分娩的1219例SARS-CoV-2阳性单胎孕妇。
  • 疾病严重程度按美国国立卫生研究院(NIH)标准分类。

主要发现

  • 1219例中47%无症状、27%轻型、14%中型、8%重型、4%危重型。
  • 4例(0.3%)孕产妇死亡归因于COVID-19。
  • 重度-危重型患者静脉血栓栓塞发生率为6%(95%CI 2-11%),轻-中型为0.2%,无症状为0%(P<.001)。
  • 校正分析显示,与无症状者相比,重度-危重型COVID-19与剖宫产(59.6% vs 34.0%,aRR 1.57,95%CI 1.30-1.90)、妊娠期高血压疾病(40.4% vs 18.8%,aRR 1.61,95%CI 1.18-2.20)和早产(41.8% vs 11.9%,aRR 3.53,95%CI 2.42-5.14)风险增加相关。
  • 轻-中型COVID-19与无症状者相比未增加不良围产结局风险。

关键数值与推荐

  • 疾病严重程度分类采用NIH标准。
  • 围产儿死亡或新生儿SARS-CoV-2阳性率在不同严重程度间无差异。

临床怎么用

  • 对重度-危重型COVID-19孕妇应加强监测,警惕静脉血栓栓塞、妊娠期高血压疾病和早产,并做好剖宫产准备。
  • 轻-中型COVID-19孕妇的围产管理可参照无症状感染者,但仍需个体化评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe coronavirus disease 2019 (COVID-19) severity in pregnant patients and evaluate the association between disease severity and perinatal outcomes. METHODS: We conducted an observational cohort study of all pregnant patients with a singleton gestation and a positive test result for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who delivered at 1 of 33 U.S. hospitals in 14 states from March 1 to July 31, 2020. Disease severity was classified by National Institutes of Health criteria. Maternal, fetal, and neonatal outcomes were abstracted by centrally trained and certified perinatal research staff. We evaluated trends in maternal characteristics and outcomes across COVID-19 severity classes and associations between severity and outcomes by multivariable modeling. RESULTS: A total of 1,219 patients were included: 47% asymptomatic, 27% mild, 14% moderate, 8% severe, 4% critical. Overall, 53% were Hispanic; there was no trend in race-ethnicity distribution by disease severity. Those with more severe illness had older mean age, higher median body mass index, and pre-existing medical comorbidities. Four maternal deaths (0.3%) were attributed to COVID-19. Frequency of perinatal death or a positive neonatal SARS-CoV-2 test result did not differ by severity. Adverse perinatal outcomes were more frequent among patients with more severe illness, including 6% (95% CI 2-11%) incidence of venous thromboembolism among those with severe-critical illness compared with 0.2% in mild-moderate and 0% in asymptomatic (P<.001 for trend across severity). In adjusted analyses, severe-critical COVID-19 was associated with increased risk of cesarean birth (59.6% vs 34.0%, adjusted relative risk [aRR] 1.57, 95% CI 1.30-1.90), hypertensive disorders of pregnancy (40.4% vs 18.8%, aRR 1.61, 95% CI 1.18-2.20), and preterm birth (41.8% vs 11.9%, aRR 3.53, 95% CI 2.42-5.14) compared with asymptomatic patients. Mild-moderate COVID-19 was not associated with adverse perinatal outcomes compared with asymptomatic patients. CONCLUSION: Compared with pregnant patients with SARS-CoV-2 infection without symptoms, those with severe-critical COVID-19, but not those with mild-moderate COVID-19, were at increased risk of perinatal complications.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Metz TD, Clifton RG, Hughes BL, et al. Disease Severity and Perinatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 (COVID-19). Obstet Gynecol. 2021. PMID: 33560778. doi:10.1097/AOG.0000000000004339

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。